Vanda Pharmaceuticals Inc
NASDAQ:VNDA

Watchlist Manager
Vanda Pharmaceuticals Inc Logo
Vanda Pharmaceuticals Inc
NASDAQ:VNDA
Watchlist
Price: 5.02 USD 3.29% Market Closed
Market Cap: 295.8m USD
Have any thoughts about
Vanda Pharmaceuticals Inc?
Write Note

Wall Street
Price Targets

VNDA Price Targets Summary
Vanda Pharmaceuticals Inc

Wall Street analysts forecast VNDA stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for VNDA is 12.92 USD with a low forecast of 5.05 USD and a high forecast of 21 USD.

Lowest
Price Target
5.05 USD
1% Upside
Average
Price Target
12.92 USD
157% Upside
Highest
Price Target
21 USD
318% Upside
Vanda Pharmaceuticals Inc Competitors:
Price Targets
ZBIO
Zenas Biopharma Inc
214% Upside
MAB
Mabion SA
6% Downside
COV
Covalon Technologies Ltd
47% Upside
SKYE
Skye Bioscience Inc
316% Upside
AKBA
Akebia Therapeutics Inc
89% Upside
CRSP
CRISPR Therapeutics AG
36% Upside
377740
BioNote Inc
11% Upside
NRIX
Nurix Therapeutics Inc
134% Upside

Revenue
Forecast

Revenue Estimate
Vanda Pharmaceuticals Inc

For the last 13 years the compound annual growth rate for Vanda Pharmaceuticals Inc's revenue is 15%. The projected CAGR for the next 3 years is 23%.

15%
Past Growth
23%
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Vanda Pharmaceuticals Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
5%
Average Beat

Net Income
Forecast

Net Income Estimate
Vanda Pharmaceuticals Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-14%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is VNDA's stock price target?
Price Target
12.92 USD

According to Wall Street analysts, the average 1-year price target for VNDA is 12.92 USD with a low forecast of 5.05 USD and a high forecast of 21 USD.

What is Vanda Pharmaceuticals Inc's Revenue forecast?
Projected CAGR
23%

For the last 13 years the compound annual growth rate for Vanda Pharmaceuticals Inc's revenue is 15%. The projected CAGR for the next 3 years is 23%.

Back to Top